With more than 20 years of experience in dermoscopy, MoleMax Systems (as a division of Macquarie Medical Systems) focuses on delivering safe, high quality and efficient tools which help medical practices implement strategies for the best patient-centred care.
Our vision is to revolutionise and redefine the traditional MoleMax digital skin imaging system by making it a more economical and effective tool for image capture for clinical documentation to support workflow efficiency and improve patient care.
With more than 20 years of experience in dermoscopy, MoleMax Systems (as a division of Macquarie Medical Systems) focuses on delivering safe, high quality and efficient tools which help medical practices implement strategies for the best patient-centred care.
Our vision is to revolutionise and redefine the traditional MoleMax digital skin imaging system by making it a more economical and effective tool for image capture for clinical documentation to support workflow efficiency and improve patient care.
With more than 20 years of experience in dermoscopy, MoleMax Systems (as a division of Macquarie Medical Systems) focuses on delivering safe, high quality and efficient tools which help medical practices implement strategies for the best patient-centred care.
Our vision is to revolutionise and redefine the traditional MoleMax digital skin imaging system by making it a more economical and effective tool for image capture for clinical documentation to support workflow efficiency and improve patient care.
With more than 20 years of experience in dermoscopy, MoleMax Systems (as a division of Macquarie Medical Systems) focuses on delivering safe, high quality and efficient tools which help medical practices implement strategies for the best patient-centred care.
Our vision is to revolutionise and redefine the traditional MoleMax digital skin imaging system by making it a more economical and effective tool for image capture for clinical documentation to support workflow efficiency and improve patient care.
With more than 20 years of experience in dermoscopy, MoleMax Systems a division of Macquarie Medical Systems, is dedicated to delivering safe, high-quality and efficient technologies that enable healthcare professionals to provide the highest standard of patient-centred skin cancer care. Derma Medical Systems launched the MoleMax Digital Skin Imaging System in 1997 in Sydney Australia.
It was the first integrated system in the world for digital microscopy and macro imaging. It was a joint development with researchers at the Department of Dermatology at the University of Vienna. Developed in collaboration with dermatologists and leading clinics, it was designed specifically to meet the needs of modern dermatology practices.
Following an enthusiastic market response and extensive clinical evaluation, the platform has been continually refined and enhanced, evolving into the mature, well-engineered system available today. Today we have revolutionised the MoleMax product into a new Australian Made and Designed compact system, The MoleMax Lite. Trusted by advanced dermatology clinics and private practices in more than 70 countries, it has become a leading solution for skin imaging and lesion documentation worldwide.
The MoleMax Systems range is sold and serviced directly through our Derma Medical Systems international offices, based in California, United States and Vienna, Austria. These strategic operations allow us to provide local sales, customer support, training, and technical assistance to clinics, hospitals, dermatologists and healthcare providers throughout the Americas and Europe, ensuring responsive service and a deeper understanding of the needs of the US healthcare market.
Our international presence enables us to combine Australian innovation with local expertise, supporting customers across multiple regions with reliable products, ongoing education, and long-term partnerships. With a history of clinical relationships throughout the world, we are well positioned to deliver consistent service, faster support, and continuous product development driven by feedback from clinicians worldwide.
